“…Since the mid-1990s, MRSA ST30 clones with different pulsotypes and genetic characteristics have been reported from many parts of the world, including the United States, Japan, Latin America, Turkey, the Middle East, Egypt, and many countries in Western Europe (58,264,429,472,604,670,757,778,913,920). ST30 isolates reported from many regions, including PFGE type USA1100 in the United States, carry the genetic determinants of PVL and the SCCmec type IV element (58), but these clones have many spa types, suggesting continued evolution (92, 252,276,294,429,682,886 (184). Despite the high prevalence of this strain in Australia (670), it has rarely been identified on other continents (258).…”